BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36215323)

  • 1. Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial.
    Taylor SM; Korwa S; Wu A; Green CL; Freedman B; Clapp S; Kirui JK; O'Meara WP; Njuguna FM
    PLoS Med; 2022 Oct; 19(10):e1004104. PubMed ID: 36215323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.
    Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G
    PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
    Barsosio HC; Madanitsa M; Ondieki ED; Dodd J; Onyango ED; Otieno K; Wang D; Hill J; Mwapasa V; Phiri KS; Maleta K; Taegtmeyer M; Kariuki S; Schmiegelow C; Gutman JR; Ter Kuile FO
    Lancet; 2024 Jan; 403(10424):365-378. PubMed ID: 38224710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy and safety of three antimalarial regimens for the prevention of malaria in young Ugandan children: a randomized controlled trial.
    Bigira V; Kapisi J; Clark TD; Kinara S; Mwangwa F; Muhindo MK; Osterbauer B; Aweeka FT; Huang L; Achan J; Havlir DV; Rosenthal PJ; Kamya MR; Dorsey G
    PLoS Med; 2014 Aug; 11(8):e1001689. PubMed ID: 25093754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of intermittent preventive treatment of malaria in pregnancy with dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine on the incidence of malaria in infancy: a randomized controlled trial.
    Kakuru A; Jagannathan P; Kajubi R; Ochieng T; Ochokoru H; Nakalembe M; Clark TD; Ruel T; Staedke SG; Chandramohan D; Havlir DV; Kamya MR; Dorsey G
    BMC Med; 2020 Aug; 18(1):207. PubMed ID: 32772921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
    Mutabingwa TK; Muze K; Ord R; Briceño M; Greenwood BM; Drakeley C; Whitty CJ
    PLoS One; 2009; 4(4):e5138. PubMed ID: 19352498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.
    Dicko A; Barry A; Dicko M; Diallo AI; Tembine I; Dicko Y; Dara N; Sidibe Y; Santara G; Conaré T; Chandramohan D; Cousens S; Milligan PJ; Diallo DA; Doumbo OK; Greenwood B
    PLoS One; 2011; 6(8):e23390. PubMed ID: 21858096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
    Kayentao K; Maiga H; Newman RD; McMorrow ML; Hoppe A; Yattara O; Traore H; Kone Y; Guirou EA; Saye R; Traore B; Djimde A; Doumbo OK
    Malar J; 2009 Jan; 8():5. PubMed ID: 19128455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon.
    Basco LK; Same-Ekobo A; Ngane VF; Ndounga M; Metoh T; Ringwald P; Soula G
    Bull World Health Organ; 2002; 80(7):538-45. PubMed ID: 12163917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monthly sulphadoxine-pyrimethamine combination versus daily proguanil for malaria chemoprophylaxis in sickle cell disease: a randomized controlled study at the Jos University Teaching Hospital.
    Dawam JA; Madaki JKA; Gambazai AA; Okpe ES; Lar-ndam N; Onu A; Gyang M
    Niger J Med; 2016; 25(2):119-27. PubMed ID: 29944308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali.
    Maiga H; Djimde AA; Beavogui AH; Toure O; Tekete M; Sangare CP; Dara A; Traore ZI; Traore OB; Dama S; N'Dong C; Niangaly H; Diallo N; Dembele D; Sagara I; Doumbo OK
    Malar J; 2015 Feb; 14():64. PubMed ID: 25889633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.
    Nkosi-Gondwe T; Robberstad B; Opoka R; Kalibbala D; Rujumba J; Galileya LT; Akun P; Nambatya W; Ssenkusu J; TerKuile F; Phiri K; Idro R
    Trials; 2023 Apr; 24(1):257. PubMed ID: 37016392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria.
    Bukirwa H; Critchley J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004966. PubMed ID: 16437507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
    Dicko A; Roh ME; Diawara H; Mahamar A; Soumare HM; Lanke K; Bradley J; Sanogo K; Kone DT; Diarra K; Keita S; Issiaka D; Traore SF; McCulloch C; Stone WJR; Hwang J; Müller O; Brown JM; Srinivasan V; Drakeley C; Gosling R; Chen I; Bousema T
    Lancet Infect Dis; 2018 Jun; 18(6):627-639. PubMed ID: 29422384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
    Cisse B; Cairns M; Faye E; NDiaye O; Faye B; Cames C; Cheng Y; NDiaye M; Lô AC; Simondon K; Trape JF; Faye O; NDiaye JL; Gaye O; Greenwood B; Milligan P
    PLoS One; 2009 Sep; 4(9):e7164. PubMed ID: 19784374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis.
    Gutman J; Kovacs S; Dorsey G; Stergachis A; Ter Kuile FO
    Lancet Infect Dis; 2017 Feb; 17(2):184-193. PubMed ID: 27865890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.
    Konaté AT; Yaro JB; Ouédraogo AZ; Diarra A; Gansané A; Soulama I; Kangoyé DT; Kaboré Y; Ouédraogo E; Ouédraogo A; Tiono AB; Ouédraogo IN; Chandramohan D; Cousens S; Milligan PJ; Sirima SB; Greenwood BM; Diallo DA
    PLoS One; 2011; 6(8):e23391. PubMed ID: 21858097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda: stakeholder engagement meeting report.
    Hill J;
    Malar J; 2024 Mar; 23(1):89. PubMed ID: 38539181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Seasonal Malaria Chemoprevention in Children under Ten Years of Age in Senegal: A Stepped-Wedge Cluster-Randomised Trial.
    Cissé B; Ba EH; Sokhna C; NDiaye JL; Gomis JF; Dial Y; Pitt C; NDiaye M; Cairns M; Faye E; NDiaye M; Lo A; Tine R; Faye S; Faye B; Sy O; Konate L; Kouevijdin E; Flach C; Faye O; Trape JF; Sutherland C; Fall FB; Thior PM; Faye OK; Greenwood B; Gaye O; Milligan P
    PLoS Med; 2016 Nov; 13(11):e1002175. PubMed ID: 27875528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.